SION

Sionna Therapeutics

• TipRanks·3d ago

  Sionna Therapeutics to present at 2026 North American Cystic Fibrosis Conference

• TipRanks·09/19 14:35

  LifeSci Capital Sticks to Its Hold Rating for Sionna Therapeutics, Inc. (SION)

• NASDAQ·09/18 14:44

  Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead

• Seeking Alpha·09/18 14:20

  10 small-cap U.S. healthcare stocks with the weakest momentum grades

• Seeking Alpha·09/18 13:55

  Small-cap stocks with weak momentum grades and steep YTD losses

• TipRanks·09/16 11:10

  Analysts’ Opinions Are Mixed on These NA Stocks: HealthStream (HSTM), Inter Parfums (IPAR) and Sionna Therapeutics, Inc. (SION)

• NASDAQ·09/15 14:08

  Sionna Advances New CF Combo To Phase 2a After SION-719 Setback, Cuts Workforce 46%; Stock Down

• Dow Jones·09/15 13:46

  Sionna Therapeutics Is Maintained at Neutral by Wedbush

• Benzinga·09/15 13:36

  Wedbush Maintains Neutral on Sionna Therapeutics, Raises Price Target to $6

• TipRanks·09/15 12:00

  Sionna Therapeutics price target raised to $6 from $5 at Wedbush

• TipRanks·09/15 11:20

  Analysts Offer Insights on NA Companies: Jack Henry & Associates (JKHY) and Sionna Therapeutics, Inc. (SION)

• TipRanks·09/15 10:46

  Stifel Nicolaus Keeps Their Hold Rating on Sionna Therapeutics, Inc. (SION)

• TipRanks·09/14 20:30

  Sionna Therapeutics Restructures to Focus on Dual Combination

• Dow Jones·09/14 20:28

  Sionna Therapeutics to Cut 46% of Staff to Focus on Cystic Fibrosis Drug Development

• TipRanks·09/14 20:05

  Sionna Therapeutics to advance SION-451 + SION-2222 into AscenSION CF POC trial